Acyclovir
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
17856-8083 -
Package NDC
17856-8083-1 -
Application number
ANDA074738 -
SPL ID
4032ed04-0061-c22c-e063-6394a90a2ba1 -
SPL set ID
4032ce02-e2b3-d426-e063-6294a90ab6c9 -
UNII
X4HES1O11F -
RxCUI
307730
What the source publishes
- Labeler
- ATLANTIC BIOLOGICALS CORP.
- Active ingredients
- Acyclovir
- Form
- SUSPENSION
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Acyclovir",
"splId": "4032ed04-0061-c22c-e063-6394a90a2ba1",
"labels": [
{
"setId": "4032ce02-e2b3-d426-e063-6294a90ab6c9",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4032ce02-e2b3-d426-e063-6294a90ab6c9",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4032ce02-e2b3-d426-e063-6294a90ab6c9"
}
],
"routes": [
"ORAL"
],
"labeler": "ATLANTIC BIOLOGICALS CORP.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "50 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (17856-8083-1) / 5 mL in 1 CUP, UNIT-DOSE",
"package_ndc": "17856-8083-1",
"identifierStatus": "well-formed",
"marketing_start_date": "20251001"
}
],
"productId": "17856-8083_4032ed04-0061-c22c-e063-6394a90a2ba1",
"useDomain": "unknown",
"dosageForm": "SUSPENSION",
"productNdc": "17856-8083",
"deaSchedule": null,
"genericName": "Acyclovir",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "ACYCLOVIR",
"strength": "200 mg/5mL"
}
],
"applicationNumber": "ANDA074738",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20020903",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000020060",
"N0000180187",
"N0000180188",
"N0000175468",
"N0000175459"
],
"unii": [
"X4HES1O11F"
],
"rxcui": [
"307730"
],
"spl_set_id": [
"4032ce02-e2b3-d426-e063-6294a90ab6c9"
],
"pharm_class_epc": [
"Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]",
"Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]",
"Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"
],
"pharm_class_moa": [
"DNA Polymerase Inhibitors [MoA]"
],
"manufacturer_name": [
"ATLANTIC BIOLOGICALS CORP."
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:17856-8083_4032ed04-0061-c22c-e063-6394a90a2ba1"